Stratec
Price
Price
Historical dividends and forecast
Stratec has so far distributed $0.595 in 2024. The next dividend will be paid on 22.05.2025
CHART BY
Frequently asked questions
What is Stratec's market capitalization?
What is Stratec's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Stratec?
What are the analyst ratings and target price for Stratec's stock?
What is Stratec's revenue over the trailing twelve months?
What is the EBITDA for Stratec?
What is the free cash flow of Stratec?
What is the 5-year beta of Stratec's stock?
How many employees does Stratec have, and what sector and industry does it belong to?
What is the free float of Stratec's shares?
Financials
Market Cap
$355.95M5Y beta
0.19EPS (TTM)
$0.863Free Float
7.23MP/E ratio (TTM)
33.94Revenue (TTM)
$262.43MEBITDA (TTM)
$42.28MFree Cashflow (TTM)
$19.24MPricing
Analyst Ratings
The price target is $44.83 and the stock is covered by 10 analysts.
Buy
1
Hold
7
Sell
2
Information
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
1,462
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker